In one paragraphArticle in The Journal of experimental medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
21 authors.
Quin T WaterburyDivision of Digestive and Liver Diseases, Department of Medicine and Irving Cancer Research Center, Department of Medicine, Columbia University Medical Center, New York, NY, USA.ORCID 0000-0001-6394-9895 Jin QianDivision of Digestive and Liver Diseases, Department of Medicine and Irving Cancer Research Center, Department of Medicine, Columbia University Medical Center, New York, NY, USA.ORCID 0000-0002-9684-1685 Hualong ZhengDivision of Digestive and Liver Diseases, Department of Medicine and Irving Cancer Research Center, Department of Medicine, Columbia University Medical Center, New York, NY, USA.ORCID 0000-0002-2749-0113 Amanda DirnbergerDepartment of Visceral Surgery, Clarunis, University Digestive Health Care Center Basel, St. Claraspital and University Hospital Basel, Basel, Switzerland.ORCID 0000-0002-9134-2502 Oakley C OlsonDepartment of Genetics and Development, Columbia Stem Cell Initiative, Columbia University Irving Medical Center, New York, NY, USA.ORCID 0000-0002-0716-5380 Ruth A WhiteDivision of Hematology and Medical Oncology, Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA.ORCID 0000-0002-4274-4468 Feijing WuDivision of Digestive and Liver Diseases, Department of Medicine and Irving Cancer Research Center, Department of Medicine, Columbia University Medical Center, New York, NY, USA.ORCID 0000-0001-9198-7960 Hiroki KobayashiDivision of Digestive and Liver Diseases, Department of Medicine and Irving Cancer Research Center, Department of Medicine, Columbia University Medical Center, New York, NY, USA.ORCID 0000-0002-1717-4870 Ermanno MalagolaDivision of Digestive and Liver Diseases, Department of Medicine and Irving Cancer Research Center, Department of Medicine, Columbia University Medical Center, New York, NY, USA.ORCID 0000-0001-9294-3097 Yosuke OchiaiDivision of Digestive and Liver Diseases, Department of Medicine and Irving Cancer Research Center, Department of Medicine, Columbia University Medical Center, New York, NY, USA.ORCID 0000-0003-3069-1175 Ruhong TuDivision of Digestive and Liver Diseases, Department of Medicine and Irving Cancer Research Center, Department of Medicine, Columbia University Medical Center, New York, NY, USA.ORCID 0000-0002-7491-3879 Biyun ZhengDivision of Digestive and Liver Diseases, Department of Medicine and Irving Cancer Research Center, Department of Medicine, Columbia University Medical Center, New York, NY, USA.ORCID 0000-0001-7680-8661 Adama DiabyDivision of Digestive and Liver Diseases, Department of Medicine and Irving Cancer Research Center, Department of Medicine, Columbia University Medical Center, New York, NY, USA.ORCID 0009-0003-1718-9321 Harry NagendraDivision of Digestive and Liver Diseases, Department of Medicine and Irving Cancer Research Center, Department of Medicine, Columbia University Medical Center, New York, NY, USA.ORCID 0009-0001-8980-339X Jonathan S LaBellaDivision of Digestive and Liver Diseases, Department of Medicine and Irving Cancer Research Center, Department of Medicine, Columbia University Medical Center, New York, NY, USA.ORCID 0009-0007-6082-7287 Leah ZamechekDivision of Digestive and Liver Diseases, Department of Medicine and Irving Cancer Research Center, Department of Medicine, Columbia University Medical Center, New York, NY, USA.ORCID 0000-0003-2863-2950 Judith KornerDivision of Endocrinology, Department of Medicine, Columbia University, New York, NY, USA.ORCID 0000-0001-5989-8001 Ana B EmilianoDepartment of Medicine, Naomi Berrie Diabetes Center, Columbia University, New York, NY, USA.ORCID 0000-0001-6831-985X Anthony W FerranteInstitute of Human Nutrition, Columbia University Medical Center , New York, NY, USA.ORCID 0000-0001-9272-2593 Emmanuelle PasseguéDepartment of Genetics and Development, Columbia Stem Cell Initiative, Columbia University Irving Medical Center, New York, NY, USA.ORCID 0000-0002-3516-297X Timothy C WangDivision of Digestive and Liver Diseases, Department of Medicine and Irving Cancer Research Center, Department of Medicine, Columbia University Medical Center, New York, NY, USA.ORCID 0000-0001-5730-3019 Funding
Tumor Biology and Microenvironment ProgramP30CA013696 · COLUMBIA UNIV NEW YORK MORNINGSIDE · 1985 to 2025
$22.9MClinical and Translational Science AwardUL1TR001873 · COLUMBIA UNIVERSITY HEALTH SCIENCES · 2025 to 2025
$10.0MThe Role of Stem Cells and the Microenvironment in Gastrointestinal CancersR35CA210088 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · 2021 to 2025
$3.7MNUTRITIONT32DK007647 · COLUMBIA UNIV NEW YORK MORNINGSIDE · 1990 to 2025
$1.7MREGULATION OF HISTIDINE DECARBOXYLASE GENE EXPRESSIONR01DK048077 · UNIV OF MASSACHUSETTS MED SCH WORCESTER · 1995 to 2005
$1.6MThe Organoid and Cell Culture CoreP30DK132710 · COLUMBIA UNIVERSITY HEALTH SCIENCES · 2025 to 2025
$1.2MImmature neutrophil migration promotes inflammation during obesityF31DK142531 · COLUMBIA UNIVERSITY HEALTH SCIENCES · 2025 to 2025
$50kColumbia University Institute of Human Nutrition T32DK007647Department of Defense W81XWH-21-1-0901NCATS NIH HHS UL1 TR001873NCATS NIH HHS UL1TR001873NCI NIH HHS P30 CA013696NCI NIH HHS P30CA013696NCI NIH HHS R01DK48077NCI NIH HHS R35 CA210088NCI NIH HHS R35CA210088NIDDK NIH HHS 5P30DK132710NIDDK NIH HHS F31 DK142531NIDDK NIH HHS F31DW142531NIDDK NIH HHS P30 DK132710NIDDK NIH HHS R01 DK048077NIDDK NIH HHS T32 DK007647NIH HHS
6 · The paper itselfAbstract
The bone marrow (BM) is altered in obesity to promote myeloid cell generation, but the mechanisms driving these changes remain unclear. Here, we show that obesogenic stimuli promote adipose tissue macrophages to recruit neutrophils from the BM in mice. Recruitment of BM neutrophils activates hematopoietic stem cells, which produce myeloid cells that accumulate in the circulation and drive inflammation. This recruitment is not resolved by weight loss, leading to sustained myelopoiesis in previously obese mice. Inhibiting neutrophil recruitment out of the BM in obese mice or during weight loss reduces BM myelopoiesis and adipose tissue inflammation, and improves glucose tolerance. In humans with obesity, plasma neutrophil chemokines are increased, correlate with increased insulin resistance, but do not decrease with weight loss. Our results demonstrate that neutrophil recruitment is a key mediator of myelopoiesis during obesity, and targeting this pathway is a potential strategy to improve inflammation during obesity and weight loss.
Indexed as
Bone MarrowBone Marrow CellsMyelopoiesisNeutrophilsObesityWeight LossAdipose TissueAnimalsHematopoietic Stem CellsHumansInflammationInsulin ResistanceMacrophagesMaleMiceMice, Inbred C57BL
Identifiers
PMID40644598
PMCPMC12263173
What Socratic holds
Textmetadata
Read underepoch 390